Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2
Introduction 10
2.1 What Is This Report About? 10
3 Executive Summary
11
4 Definitions of Markets Covered in the Report 12
4.1 Diabetic Care
Devices 12
4.2 Glucose Monitoring Devices 12
4.2.1 Blood Glucose
Meters 12
4.2.2 Blood Glucose Strips 12
4.3 Insulin Delivery 12
4.3.1 Insulin Pens 12
4.3.2 Insulin Syringes 13
4.3.3 Insulin Pumps
13
4.3.4 Traditional Insulin Pump Accessories 13
5 Healthcare Sector
Review 14
5.1 Healthcare Expenditure 14
5.2 Healthcare Infrastructure
15
5.3 Healthcare Policy 17
5.4 UK Healthcare Trade Statistics 18
6 Regulation System 19
6.1 Medical Equipment Approval Process 19
6.1.1
Classification of Medical Devices 19
6.1.2 Conformity Assessment Process
27
6.2 Medical Device approval fee 32
6.3 Post Market Surveillance
(PMS) 33
7 Pricing and Reimbursement 34
7.1 Market Pricing 34
7.2
Government Policies for Reimbursement 34
8 Distribution Structure 36
9
Diabetes Care Devices In UK 37
9.1 Diabetes Care Devices, UK, Overall
Revenue ($ mn), 2000-2015 37
9.2 Diabetes Care Devices, UK, Category
Volume (Units), 2000-2015 40
9.3 Diabetes Care Devices, UK, Cross-Category
Analysis, 2000-2015 42
9.4 Diabetes Care Devices, UK, Company Share
(2007-2008) 43
10 Glucose Monitoring In UK 45
10.1 Glucose Monitoring
Overall Revenue (2000-2015) 45
10.1.1 Blood Glucose Meters Overall Revenue
(2000-2015) 47
10.2 Glucose Monitoring Overall Volume (2000-2015) 49
10.2.1 Blood Glucose Meters Overall Volume (2000-2015) 50
10.3 Glucose
Monitoring, UK, Cross-Segment Analysis, 2000-2015 52
10.4 Glucose
Monitoring Average Price (2000-2015) 53
10.5 Glucose Monitoring Market
Dynamics 54
10.5.1 Market Drivers 54
10.5.2 Market Restraints 54
10.6 Glucose Monitoring Distribution Share (2007-2008) 55
10.7 Glucose
Monitoring, UK, Company Share (2007-2008) 55
11 Insulin Delivery In UK
57
11.1 Insulin Delivery Overall Revenue (2000-2015) 57
11.1.1 Insulin
Pens Overall Revenue (2000-2015) 60
11.2 Insulin Delivery Overall Volume
(2000-2015) 62
11.2.1 Insulin Pens Overall Volume (2000-2015) 63
11.3
Insulin Delivery, UK, Cross-Segment Analysis, 2000-2015 65
11.4 Insulin
Delivery Average Price (2000-2015) 66
11.5 Insulin Delivery Market
Dynamics 67
11.6 Insulin Delivery Distribution Share (2007-2008) 68
11.7 Insulin Delivery, UK, Company Share (2007-2008) 68
12 Overview of Key
Companies in UK Diabetes Care Devices Market 70
12.1 F. Hoffmann-La Roche
Ltd. 70
12.1.1 Company Overview 70
12.1.2 F. Hoffmann-La Roche Ltd
Pipeline Products 73
12.2 LifeScan, Inc. 74
12.2.1 Company Overview
74
12.2.2 LifeScan, Inc. Pipeline Products 74
12.3 Bayer HealthCare AG
76
12.3.1 Company Overview 76
12.3.2 Bayer HealthCare AG Pipeline
Products 79
12.4 Abbott Laboratories 81
12.4.1 Company Overview 81
12.4.2 Abbott Laboratories Pipeline Products 84
12.5 Novo Nordisk A/S
86
12.5.1 Company Overview 86
12.5.2 Novo Nordisk A/S Pipeline
Products 86
12.6 Becton, Dickinson and Company 88
12.6.1 Company
Overview 88
12.7 Eli Lilly and Company 90
12.7.1 Company Overview
90
12.7.2 Eli Lilly and Company Pipeline Products 93
12.8 Medtronic,
Inc. 94
12.8.1 Company Overview 94
12.8.2 Medtronic, Inc. Pipeline
Products 96
12.9 ARKRAY, Inc. 103
12.9.1 Company Overview 103
12.9.2 ARKRAY, Inc. Pipeline Products 103
12.10 Terumo Corporation 105
12.10.1 Company Overview 105
12.11 Animas Corporation 107
12.11.1
Company Overview 107
12.12 Sanofi-Aventis 107
12.12.1 Company Overview
107
12.13 Smiths Medical 108
12.13.1 Company Overview 108
13
Recent Developments 111
13.1 Strategy And Business Planning 111
13.1.1
Mar 25, 2009: Smiths Medical Intents To Stop Selling Deltec Cozmo Insulin
Pumps 111
13.2 Government and Public Interest 112
13.2.1 Apr 29, 2009:
Warning About Failing Insulin Infusion Pump, UK 112
13.3 Product News
113
13.3.1 Mar 19, 2009: Accu-Chek Inform II Blood Glucose Monitoring
System Helps To Improve Patient Care 113
13.3.2 Feb 03, 2009: Accu-Chek
Aviva Nano Designed To Motivate Patients For Self-Management Of Diabetes
113
14 Appendix 115
14.1 GlobalData Research Methodology 115
14.2
Coverage 116
14.3 Secondary Research 117
14.4 Primary Research 117
14.5 Models 118
14.6 Forecasts 118
14.7 Expert Panel Validation
119
14.8 Currency Conversion 120
14.9 Contact Us 121
14.10
Disclaimer 121
1.1 List of Tables
Table 1: Number of Doctor by
Specialty in UK, 2003 - 2007 16
Table 2: UK Healthcare Trade Statistics,
2001-2006 18
Table 3: Medical Device Approval Fee in UK, 2006 32
Table
4: Diabetes Care Devices, UK, Overall Revenue ($ mn), Historic, 2000-2008
37
Table 5: Diabetes Care Devices, UK, Overall Revenue ($ mn),
Forecast, 2008-2015 39
Table 6: Diabetes Care Devices, UK, Category
Volume (Units), Historic, 2000-2008 40
Table 7: Diabetes Care
Devices, UK, Category Volume (Units), Forecast, 2008-2015 41
Table 8:
Diabetes Care Devices, UK, Cross-Category Analysis, 2000-2015 42
Table 9:
Diabetes Care Devices, UK, Company Share by Revenue ($ mn), 2007-2008
43
Table 10: Glucose Monitoring, UK, Revenue ($ mn) by Segment,
Historic, 2000-2008 45
Table 11: Glucose Monitoring, UK, Revenue ($
mn) by Segment, Forecast, 2008-2015 46
Table 12: Blood Glucose
Meters, UK, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 47
Table
13: Blood Glucose Meters, UK, Revenue ($ mn) by Sub-Segment, Forecast,
2008-2015 48
Table 14: Glucose Monitoring, UK, Volume (Units) by
Segment, Historic, 2000-2008 49
Table 15: Glucose Monitoring, UK,
Volume (Units) by Segment, Forecast, 2008-2015 49
Table 16: Blood
Glucose Meters, UK, Volume (Units) by Sub-Segment, Historic, 2000-2008 50
Table 17: Blood Glucose Meters, UK, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 51
Table 18: Glucose Monitoring, UK,
Cross-Segment Analysis, 2000-2015 52
Table 19: Glucose Monitoring,
UK, Average Price ($), Historic, 2000-2008 53
Table 20: Glucose
Monitoring, UK, Average Price ($), Forecast, 2008-2015 53
Table 21:
Glucose Monitoring, UK, Distribution Share by Revenue ($mn), 2007-2008 55
Table 22: Glucose Monitoring, UK, Company Share by Revenue ($ mn),
2007-2008 56
Table 23: Insulin Delivery, UK, Revenue ($ mn) by
Segment, Historic, 2000-2008 57
Table 24: Insulin Delivery, UK,
Revenue ($ mn) by Segment, Forecast, 2008-2015 59
Table 25: Insulin
Pens, UK, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 60
Table 26:
Insulin Pens, UK, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
61
Table 27: Insulin Delivery, UK, Volume (Units) by Segment,
Historic, 2000-2008 62
Table 28: Insulin Delivery, UK, Volume (Units)
by Segment, Forecast, 2008-2015 62
Table 29: Insulin Pens, UK, Volume
(Units) by Sub-Segment, Historic, 2000-2008 63
Table 30: Insulin
Pens, UK, Volume (Units) by Sub-Segment, Forecast, 2008-2015 64
Table 31:
Insulin Delivery, UK, Cross-Segment Analysis, 2000-2015 65
Table 32:
Insulin Delivery, UK, Average Price ($), Historic, 2000-2008 66
Table
33: Insulin Delivery, UK, Average Price ($), Forecast, 2008-2015 66
Table 34: Insulin Delivery, UK, Distribution Share by Revenue ($mn),
2007-2008 68
Table 35: Insulin Delivery, UK, Company Share by Revenue
($ mn), 2007-2008 69
Table 36: F. Hoffmann-La Roche Ltd Pipeline
Products by Equipment Type 73
Table 37: F. Hoffmann-La Roche Ltd
Pipeline Products by Development Stage 73
Table 38: F. Hoffmann-La
Roche Ltd Pipeline Products by Therapy Area 73
Table 39: LifeScan,
Inc. Pipeline Products by Equipment Type 74
Table 40: LifeScan, Inc.
Pipeline Products by Development Stage 74
Table 41: LifeScan, Inc.
Pipeline Products by Therapy Area 74
Table 42: LifeScan, Inc.
Pipeline Products by Clinical Trials 75
Table 43: LifeScan, Inc.
Pipeline Products by News Summary 75
Table 44: Bayer HealthCare AG
Pipeline Products by Equipment Type 79
Table 45: Bayer HealthCare AG
Pipeline Products by Development Stage 79
Table 46: Bayer HealthCare
AG Pipeline Products by Therapy Area 79
Table 47: Bayer HealthCare AG
Pipeline Products by News Summary 80
Table 48: Abbott Laboratories
Pipeline Products by Equipment Type 84
Table 49: Abbott Laboratories
Pipeline Products by Development Stage 84
Table 50: Abbott
Laboratories Pipeline Products by Therapy Area 84
Table 51: Abbott
Laboratories Pipeline Products by Clinical Trials 85
Table 52: Abbott
Laboratories Pipeline Products by News Summary 85
Table 53: Novo
Nordisk A/S Pipeline Products by Equipment Type 86
Table 54: Novo
Nordisk A/S Pipeline Products By Development Stage 86
Table 55: Novo
Nordisk A/S Pipeline Products By Therapy Area 87
Table 56: Novo
Nordisk A/S Pipeline Products By Clinical Trials 87
Table 57: Eli
Lilly and Company Pipeline Products by Equipment Type 93
Table 58:
Eli Lilly and Company Pipeline Products by Development Stage 93
Table 59:
Eli Lilly and Company Pipeline Products by Therapy Area 93
Table 60:
Eli Lilly and Company Pipeline Products by Clinical Trials 93
Table 61:
Eli Lilly and Company Pipeline Products by News Summary 93
Table 62:
Medtronic, Inc. Pipeline Products by Equipment Type 96
Table 63:
Medtronic, Inc. Pipeline Products By Development Stage 98
Table 64:
Medtronic, Inc. Pipeline Products By Therapy Area 99
Table 65:
Medtronic, Inc. Pipeline Products By Clinical Trials 101
Table 66:
Medtronic, Inc. Pipeline Products By News Summary 102
Table 67:
ARKRAY, Inc. Pipeline Products by Equipment Type 103
Table 68:
ARKRAY, Inc. Pipeline Products by Development Stage 103
Table 69:
ARKRAY, Inc. Pipeline Products by Clinical Trials 104
Table 70:
ARKRAY, Inc. Pipeline Products by News Summary 104
Table 71: USD to
Local Currency, Average Exchange Rate 2008 120
1.2 List of
Figures
Figure 1: Total Healthcare Expenditure in UK, 2000 - 2006 15
Figure 2: Flowchart for Classification of Non-invasive Devices in UK, 2007
20
Figure 3: Flowchart for Classification of Invasive Devices in UK, 2007
21
Figure 4: Flowchart for Classification of Invasive Devices in UK, 2007
22
Figure 5: Flowchart for Classification of Invasive Devices in UK, 2007
23
Figure 6: Flowchart for Classification of Invasive Devices in UK, 2007
24
Figure 7: Flowchart for Classification of Active Devices in UK, 2007
25
Figure 8: Flowchart for Classification of Active Devices in UK, 2007
26
Figure 9: Flowchart for Classification of Devices except Non-invasive,
Invasive and Active Devices in UK, 2007 27
Figure 10: Conformity
Assessment of Class-I Medical Devices in UK, 2007 28
Figure 11: Conformity
Assessment of Class-IIa Medical Devices in UK, 2007 29
Figure 12:
Conformity Assessment of Class-IIb Medical Devices in UK, 2007 30
Figure
13: Conformity Assessment of Class-III Medical Devices in UK, 2007 31
Figure 14: Diabetes Care Devices, UK, Overall Revenue ($ mn), Historic,
2000-2008 37
Figure 15: Diabetes Care Devices, UK, Overall Revenue ($
mn), Forecast, 2008-2015 38
Figure 16: Diabetes Care Devices, UK,
Category Volume (Units), Historic, 2000-2008 40
Figure 17: Diabetes
Care Devices, UK, Category Volume (Units), Forecast, 2008-2015 41
Figure
18: Diabetes Care Devices, UK, Cross-Category Analysis, 2000-2015 42
Figure 19: Diabetes Care Devices, UK, Company Share (%), 2008 43
Figure 20: Blood Glucose Meters, UK, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 47
Figure 21: Blood Glucose Meters, UK, Revenue
($ mn) by Sub-Segment, Forecast, 2008-2015 48
Figure 22: Blood
Glucose Meters, UK, Volume (Units) by Sub-Segment, Historic, 2000-2008 50
Figure 23: Blood Glucose Meters, UK, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 51
Figure 24: Glucose Monitoring, UK,
Cross-Segment Analysis, 2000-2015 52
Figure 25: Glucose Monitoring,
UK, Company Share (%), 2008 55
Figure 26: Insulin Delivery, UK,
Revenue ($ mn) by Segment, Historic, 2000-2008 57
Figure 27: Insulin
Delivery, UK, Revenue ($ mn) by Segment, Forecast, 2008-2015 58
Figure 28:
Insulin Pens, UK, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
60
Figure 29: Insulin Pens, UK, Revenue ($ mn) by Sub-Segment,
Forecast, 2008-2015 61
Figure 30: Insulin Pens, UK, Volume (Units) by
Sub-Segment, Historic, 2000-2008 63
Figure 31: Insulin Pens, UK,
Volume (Units) by Sub-Segment, Forecast, 2008-2015 64
Figure 32:
Insulin Delivery, UK, Cross-Segment Analysis, 2000-2015 65
Figure 33:
Insulin Delivery, UK, Company Share (%), 2008 68
Figure 34:
GlobalData Methodology 116
|
Related Report
|
View Cart
